NXGN.TA·Israel·Healthcare
Share

Nextgen Biomed Ltd

ILA 65.4

Nextgen Biomed Ltd

Share
NXGN.TA·Israel·Healthcare

ILA 65.4

Rating

3

Buy

Risk factor

Very high price volatility

Very poor trading liquidity

Weak & very vulnerable to price shocks

Profitability factor

Greatly undervalued vs peers

Very low or no dividends

Very poor margins and returns

Risk / Profitability

Risk: High

Profitability: Favourable

Risk factor

Very high price volatility

Very poor trading liquidity

Weak & very vulnerable to price shocks

Profitability factor

Greatly undervalued vs peers

Very low or no dividends

Very poor margins and returns

ILA 65.4

About

Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.

About

Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.

About

Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.

About

Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.